Longdan Xiegan Wan
Natural health product licensed in Canada
- Other names
- 999 Long Dan Xie Gan Pills (Concentrated Pills), Herbal Prime Long Dan Xie Gan Pills (Concentrated Pills), Sanjiu Long Dan Xie Gan Pills (Concentrated Pills)
- Licence holder
- Wing Quon Enterprises Ltd.
- NPN or DIN-HM
- 80027539
- Status
- Active licence
- Licence date
- 3 October 2011
- Revision date
- 24 October 2024
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Alisma plantago-aquatica subsp. orientale Source : Tubercule Extraction ratio : 3.46:1 Dry plant equivalent : 53.59 mg | 15.5 mg | Not calculated |
| Plantago asiatica Source : Seed (processed) Extraction ratio : 3.46:1 Dry plant equivalent : 26.78 mg | 7.75 mg | Not calculated |
| Angelica sinensis Source : Root (processed) | 26.78 mg | Not calculated |
| Glycyrrhiza uralensis Source : Prepared root Extraction ratio : 3.46:1 Dry plant equivalent : 13.39 mg | 3.87 mg | Not calculated |
| Glycyrrhiza uralensis Source : Prepared root | 13.39 mg | Not calculated |
| Gardenia jasminoides Source : Fruit (processed) Extraction ratio : 3.46:1 Dry plant equivalent : 26.78 mg | 7.75 mg | Not calculated |
Non-medicinal ingredients
Talc, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 8 Pilule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditionally used in Chinese medicine for damp-heat in the claim to a statement to the effect of marked by dizziness, congested eyes, tinnitus, impairment of healing, swelling and pain in the ear, pain in the hypochondriac regions, bitterness in the mouth, difficult painful micturition of dark urine, or leukorrhea due to damp heat.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80027539
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging